FDA Inspection
Shilpa Pharma Lifesciences LimitedShilpa Pharma Lifesciences Limited – FDA Inspection, Jan 19, 2018
Record Details
This FDA Inspection record concerns Shilpa Pharma Lifesciences Limited, with an inspection on January 19, 2018, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 6bcbf041-9fbc-4e76-b011-554b86ed00f9
Inspection Facts
- Inspection number
- 1038233
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Shilpa Pharma Lifesciences Limited
6| Date | Classification | Office | Project area |
|---|---|---|---|
| March 14, 2025 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 7, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 26, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 16, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 9, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Shilpa Pharma Lifesciences Limited
- FDA Inspection 1268017 - 2025-03-14
- FDA Inspection 1122653 - 2020-02-07
- FDA Inspection 1099290 - 2019-07-26
- FDA Inspection 1004337 - 2016-12-16
- FDA Inspection 926998 - 2015-03-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.